Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.96
-0.08 (-0.88%)
At close: Mar 6, 2026, 4:00 PM EST
8.92
-0.04 (-0.45%)
After-hours: Mar 6, 2026, 4:04 PM EST
Nuvectis Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 9.42 | 6.93 | 7.52 | 6.01 | 3.35 | |
| Research & Development | 18.15 | 12.92 | 14.38 | 12.03 | 2.45 | |
| Operating Expenses | 27.57 | 19.85 | 21.9 | 18.03 | 5.79 | |
| Operating Income | -27.57 | -19.85 | -21.9 | -18.03 | -5.79 | |
| Interest & Investment Income | 1.13 | 0.85 | 0.64 | 0.15 | 0 | |
| EBT Excluding Unusual Items | -26.44 | -19 | -21.26 | -17.89 | -5.79 | |
| Other Unusual Items | - | - | -1 | -1.2 | -7.1 | |
| Pretax Income | -26.44 | -19 | -22.26 | -19.09 | -12.89 | |
| Net Income | -26.44 | -19 | -22.26 | -19.09 | -12.89 | |
| Preferred Dividends & Other Adjustments | 2.43 | - | - | - | - | |
| Net Income to Common | -28.87 | -19 | -22.26 | -19.09 | -12.89 | |
| Shares Outstanding (Basic) | 22 | 17 | 16 | 13 | 4 | |
| Shares Outstanding (Diluted) | 22 | 17 | 16 | 13 | 4 | |
| Shares Change (YoY) | 27.46% | 10.01% | 22.90% | 196.55% | 9.44% | |
| EPS (Basic) | -1.32 | -1.11 | -1.43 | -1.51 | -3.02 | |
| EPS (Diluted) | -1.32 | -1.11 | -1.43 | -1.51 | -3.02 | |
| EBIT | -27.57 | -19.85 | -21.9 | -18.03 | -5.79 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.